Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
暂无分享,去创建一个
R. Storb | J. Zaucha | H. Kiem | C. Yu | R. Nash | Q. Cao | G. Sale | G. Georges | G. Niemeyer | C. D. Lothrop | Qiongfang Cao | H. Kiem | J. A. Zaucha | Cong Yu | M. Dufresne | C. Yu | Marc Dufresne
[1] C. Mahasandana,et al. Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency , 2000, Bone Marrow Transplantation.
[2] R. Colvin,et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. , 2000, The Journal of clinical investigation.
[3] J. D. Thompson,et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. , 2000, Blood.
[4] C. Pegelow,et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. , 2000, Blood.
[5] M. Andreani,et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation , 2000, Bone Marrow Transplantation.
[6] H. Deeg,et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. , 1999, Blood.
[7] H. Deeg,et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. , 1999, Blood.
[8] M. Andreani,et al. Bone marrow transplantation in adult thalassemic patients. , 1999, Blood.
[9] Eugene R. Schiff,et al. Schiff's Diseases of the Liver , 1999 .
[10] M. Martelli,et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.
[11] S. Strasser,et al. Iron overload in bone marrow transplant recipients , 1998, Bone Marrow Transplantation.
[12] H. Deeg,et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.
[13] K. Sullivan,et al. Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders , 1997 .
[14] A. Nagler,et al. Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes , 1997 .
[15] Robert H. Collins,et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] R. Storb,et al. Molecular analysis of DLA-DRBB1 polymorphism. , 1996, Tissue antigens.
[17] E. Ostrander,et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.
[18] J. Scott,et al. Bone marrow transplantation for sickle cell disease. , 1996, The New England journal of medicine.
[19] A. Nagler,et al. Second transplantation using allogeneic peripheral blood stem cells in a β‐thalassaemia major patient featuring stable mixed chimaerism , 1996, British journal of haematology.
[20] J. Scott,et al. Barriers to bone marrow transplantation for sickle cell anemia. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[21] M. Andreani,et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. , 1996, Blood.
[22] Y. Reisner,et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice , 1995, Nature Medicine.
[23] K. Whitney,et al. Genetic test for pyruvate kinase deficiency of Basenjis. , 1995, Journal of the American Veterinary Medical Association.
[24] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[25] G. Lucarelli,et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies , 1995, British journal of haematology.
[26] E. Bryant,et al. USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.
[27] K. Whitney,et al. The molecular basis of canine pyruvate kinase deficiency. , 1994, Experimental hematology.
[28] H. Deeg,et al. Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. , 1993, International journal of radiation oncology, biology, physics.
[29] G. Koren,et al. Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients. , 1993, Bone marrow transplantation.
[30] S. Cobbold,et al. Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression , 1992, European journal of immunology.
[31] U. Varanasi,et al. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. , 1992, Carcinogenesis.
[32] M. Andreani,et al. Mixed chimerism in thalassemic patients after bone marrow transplantation. , 1992, Bone marrow transplantation.
[33] U. Giger,et al. Determination of erythrocyte pyruvate kinase deficiency in Basenjis with chronic hemolytic anemia. , 1991, Journal of the American Veterinary Medical Association.
[34] W. Ladiges. 4 – Experimental Techniques Used to Study the Immune System of Dogs and Other Large Animals , 1989 .
[35] H. Kantarjian,et al. The relevance of reticulin stain‐measured fibrosis at diagnosis in chronic myelogenous leukemia , 1987, Cancer.
[36] C. Civin,et al. Flow cytometric analysis of human bone marrow: I. Normal erythroid development , 1987 .
[37] H. Fujii,et al. Change of pyruvate kinase isozymes from M2‐ to L‐type during development of the red cell , 1983, British journal of haematology.
[38] K. Sullivan,et al. MARROW TRANSPLANTATION FOR THALASSAEMIA , 1982, The Lancet.
[39] H. Deeg,et al. Long-term survival and reversal of iron overload after marrow transplantation in dogs with congenital hemolytic anemia. , 1981, Blood.
[40] D. Miller,et al. Animal model of human disease: pyruvate kinase deficiency. , 1979, The American journal of pathology.
[41] J. A. Black,et al. Hereditary persistence of fetal erythrocyte pyruvate kinase in the Basenji dog. , 1978, Progress in clinical and biological research.
[42] R. Storb,et al. HEMOPOIETIC GRAFTS BETWEEN DLA‐IDENTICAL CANINE LITTERMATES FOLLOWING DIMETHYL MYLERAN: EVIDENCE FOR RESISTANCE TO GRAFTS NOT ASSOCIATED WITH DLA AND ABROGATED BY ANTITHYMOCYTE SERUM , 1977, Transplantation.
[43] R. Storb,et al. Severe Hereditary Haemolytic Anaemia in Dogs Treated by Marrow Transplantation , 1976, British journal of haematology.
[44] E. Beutler,et al. Pyruvate kinase deficiency anemia with terminal myelofibrosis and osteosclerosis in a beagle. , 1975, Journal of the American Veterinary Medical Association.
[45] G. Bird. The red cell. , 1972 .
[46] R. Storb,et al. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion. , 1970, Cancer research.
[47] R. Storb,et al. ALLOGENEIC CANINE BONE MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE , 1969, Transplantation.
[48] A. Hope. A Simplified Monte Carlo Significance Test Procedure , 1968 .
[49] J. Heavner. Methods of animal experimentation , 1965 .